First Horizon Advisors’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.6K | Sell |
346
-31
| -8% | -$3K | ﹤0.01% | 1237 |
|
|
2025
Q1 | $42.7K | Sell |
377
-2
| -0.5% | -$214 | ﹤0.01% | 1004 |
|
|
2024
Q4 | $40K | Sell |
379
-10
| -3% | -$1.07K | ﹤0.01% | 1042 |
|
|
2024
Q3 | $42K | Buy |
389
+70
| +22% | +$7.64K | ﹤0.01% | 1063 |
|
|
2024
Q2 | $34.6K | Sell |
319
-320
| -50% | -$37.7K | ﹤0.01% | 1082 |
|
|
2024
Q1 | $84.3K | Buy |
639
+7
| +1% | +$874 | ﹤0.01% | 741 |
|
|
2023
Q4 | $76.9K | Sell |
632
-599
| -49% | -$66.8K | ﹤0.01% | 747 |
|
|
2023
Q3 | $138K | Sell |
1,231
-57
| -4% | -$7.24K | 0.01% | 543 |
|
|
2023
Q2 | $188K | Buy |
1,288
+626
| +95% | +$85.1K | 0.01% | 484 |
|
|
2023
Q1 | $85.5K | Sell |
662
-268
| -29% | -$33.6K | ﹤0.01% | 697 |
|
|
2022
Q4 | $119K | Sell |
930
-80
| -8% | -$9.28K | ﹤0.01% | 570 |
|
|
2022
Q3 | $105K | Hold |
1,010
| – | – | ﹤0.01% | 595 |
|
|
2022
Q2 | $106K | Buy |
1,010
+241
| +31% | +$28.6K | ﹤0.01% | 649 |
|
|
2022
Q1 | $98K | Sell |
769
-465
| -38% | -$56K | 0.01% | 496 |
|
|
2021
Q4 | $151K | Sell |
1,234
-25
| -2% | -$3.27K | ﹤0.01% | 559 |
|
|
2021
Q3 | $178K | Buy |
1,259
+536
| +74% | +$78.8K | 0.01% | 527 |
|
|
2021
Q2 | $112K | Sell |
723
-93
| -11% | -$15.1K | 0.01% | 517 |
|
|
2021
Q1 | $125K | Sell |
816
-60
| -7% | -$9.29K | 0.01% | 459 |
|
|
2020
Q4 | $130K | Sell |
876
-53
| -6% | -$7.49K | 0.01% | 382 |
|
|
2020
Q3 | $123K | Hold |
929
| – | – | 0.01% | 364 |
|
|
2020
Q2 | $107K | Sell |
929
-70
| -7% | -$8.07K | 0.01% | 386 |
|
|
2020
Q1 | $97K | Sell |
999
-56
| -5% | -$7.34K | 0.01% | 375 |
|
|
2019
Q4 | $152K | Buy |
1,055
+16
| +2% | +$2.21K | 0.01% | 372 |
|
|
2019
Q3 | $137K | Buy |
1,039
+120
| +13% | +$15.5K | 0.01% | 379 |
|
|
2019
Q2 | $105K | Buy |
919
+411
| +81% | +$48.1K | 0.01% | 426 |
|
|
2019
Q1 | $63K | Sell |
508
-175
| -26% | -$19.9K | 0.01% | 481 |
|
|
2018
Q4 | $69K | Sell |
683
-685
| -50% | -$77K | 0.01% | 468 |
|
|
2018
Q3 | $175K | Hold |
1,368
| – | – | 0.01% | 385 |
|
|
2018
Q2 | $148K | Buy |
1,368
+330
| +32% | +$35.9K | 0.01% | 395 |
|
|
2018
Q1 | $110K | Hold |
1,038
| – | – | 0.01% | 373 |
|
|
2017
Q4 | $121K | Hold |
1,038
| – | – | 0.01% | 378 |
|
|
2017
Q3 | $118K | Sell |
1,038
-1,611
| -61% | -$186K | 0.01% | 371 |
|
|
2017
Q2 | $330K | Hold |
2,649
| – | – | 0.04% | 250 |
|
|
2017
Q1 | $314K | Buy |
2,649
+2,223
| +522% | +$252K | 0.04% | 265 |
|
|
2016
Q4 | $53K | Hold |
426
| – | – | 0.01% | 519 |
|
|
2016
Q3 | $53K | Sell |
426
-1,328
| -76% | -$164K | 0.01% | 513 |
|
|
2016
Q2 | $205K | Sell |
1,754
-256
| -13% | -$29K | 0.03% | 295 |
|
|
2016
Q1 | $208K | Buy |
2,010
+88
| +5% | +$8.51K | 0.02% | 308 |
|
|
2015
Q4 | $192K | Sell |
1,922
-87
| -4% | -$8.51K | 0.03% | 285 |
|
|
2015
Q3 | $182K | Sell |
2,009
-8
| -0.4% | -$802 | 0.03% | 304 |
|
|
2015
Q2 | $214K | Sell |
2,017
-37
| -2% | -$4.09K | 0.03% | 292 |
|
|
2015
Q1 | $234K | Sell |
2,054
-1
| -0% | -$114 | 0.03% | 289 |
|
|
2014
Q4 | $226K | Sell |
2,055
-211
| -9% | -$22.2K | 0.03% | 292 |
|
|
2014
Q3 | $220K | Sell |
2,266
-2,442
| -52% | -$240K | 0.03% | 291 |
|
|
2014
Q2 | $474K | Sell |
4,708
-58
| -1% | -$5.66K | 0.07% | 230 |
|
|
2014
Q1 | $437K | Sell |
4,766
-100
| -2% | -$9.22K | 0.06% | 222 |
|
|
2013
Q4 | $439K | Sell |
4,866
-39
| -0.8% | -$3.38K | 0.07% | 212 |
|
|
2013
Q3 | $391K | Buy |
4,905
+4,823
| +5,882% | +$380K | 0.06% | 210 |
|
|
2013
Q2 | $6K | Buy |
+82
| New | +$6.13K | ﹤0.01% | 645 |
|
Other funds holding ZBH
First Horizon Advisors's ZBH Position: Q2 2025 in Review
First Horizon Advisors reduced its Zimmer Biomet (ZBH) stake by 8.2% in Q2 2025, selling an estimated $3K and leaving 346 shares worth $31.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1237.
First Horizon Advisors first reported a position in ZBH in Q2 2013 and has held it in 49 quarters since. The position peaked at $474K in Q2 2014. 935 funds tracked by Wall St. Rank hold ZBH as of Q2 2025.
- First Horizon Advisors held 346 shares of Zimmer Biomet worth $31.6K as of Q2 2025.
- First Horizon Advisors sold 31 Zimmer Biomet shares in Q2 2025, an estimated $3K.
- Zimmer Biomet made up ﹤0.01% of First Horizon Advisors's portfolio in Q2 2025, its #1237 holding.
- First Horizon Advisors first reported a position in Zimmer Biomet in Q2 2013 and has held it in 49 quarters since.
- First Horizon Advisors's Zimmer Biomet position peaked at $474K in Q2 2014.
- 935 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2025.
Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.